Comparison of 3 and 4 cycles of neoadjuvant gemcitabine and cisplatin for muscle-invasive bladder cancer: a systematic review and meta-analysis

Abstract Background In muscle-invasive bladder cancer (MIBC), neoadjuvant chemotherapy (NAC) combined with radical cystectomy (RC) is critical in reducing disease recurrence, with GC (gemcitabine and cisplatin) being one of the most commonly used NACs. Different GC schedules have been used, but the...

Whakaahuatanga katoa

Ngā taipitopito rārangi puna kōrero

Ngā kaituhi matua:	Lanpeng Lu, Chaohu Chen, Hui Cheng, Hui Ding, Junqiang Tian, Hanzhang Wang, Zhiping Wang
Hōputu:	Artigo
Reo:	Inglês
I whakaputaina:	BMC 2023-11-01
Rangatū:	BMC Cancer
Ngā marau:	Bladder cancer Neoadjuvant chemotherapy Gemcitabine Cisplatin
Urunga tuihono:	https://doi.org/10.1186/s12885-023-11572-0
Ngā Tūtohu:	Tāpirihia he Tūtohu Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!